International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

PreScription: Compounding Pharmacy Issues for 2017

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2017 - Volume 21, Number 1
View All Articles in Issue

Page(s): 4

PreScription: Compounding Pharmacy Issues for 2017 Page 1

Download in electronic PDF format for $75

Abstract:

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, U.S. Food and Drug Administration, FDA, Drug Quality and Security Act, DQSA, regulation, regulatory policy, state boards of pharmacy, pharmacy inspectors, pharmacy inspection, pharmaceutical benefit managers, PBM, pharmacy education, pharmacy technicians, regulatory overreach

Related Categories: BUSINESS, LEGAL, PHARMACY EDUCATION, PROFESSIONAL ISSUES

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
PreScription: Compounding Pharmacy Issues for 2017 Allen Loyd V Jr	Jan/Feb 2017 Pg. 4
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Yoch Doug	Mar/Apr 2017 Pg. 95-102
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
Regulatory and Operational Issues of Founding a Compounding Pharmacy Smith Lisa K	Nov/Dec 2002 Pg. 434-437
Applying Quality of Design Concepts to Pharmacy Compounding Timko Robert J	Nov/Dec 2015 Pg. 453-463
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr	Jan/Feb 2018 Pg. 7-16
PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing Allen Loyd V Jr	Mar/Apr 2018 Pg. 92
Standing Together Fixing the Drug Quality and Security Act Miller David G	Mar/Apr 2015 Pg. 104-106
Art of Pharmacy v. State Standridge Rob	May/Jun 2022 Pg. 182-186
U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line Snow Stephen T, Stannard Robert W, Bellis Jennifer, Moss Carrie A	Jan/Feb 2019 Pg. 32-33
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Allen Loyd V Jr	Sep/Oct 2015 Pg. 389-390
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr	Nov/Dec 2015 Pg. 487-488
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 Martin Matt	Sep/Oct 2018 Pg. 401-404
Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time Sanchez-Rubio Ferrandez J, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R	Sep/Oct 2012 Pg. 431-433
Legal & Ethical Issues for Pharmacy Websites King LD, Brashares Jennifer	Mar/Apr 2003 Pg. 88-92
The BPS Pharmacy Specialty Certification Program Bertin Richard J	May/Jun 1999 Pg. 200-203
Metro Atlanta Board - Certified Specialists' Attitudes Toward Compounding Pharmacy Greenburg Aimee R, Barnett Candace W	Jan/Feb 2004 Pg. 65-72
Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective Timko Robert J, Crooker Philip EM	Mar/Apr 2014 Pg. 101-111
Compounding Pharmacies: Before and After an Inspection Kulkarni Darshan, Ricketts Samantha	Sep/Oct 2013 Pg. 358-362
Return to Top